Record Production and Sales Growth
Total new annualized premium (NAP) was a record and up 15% for the full year; company reported its 14th consecutive quarter of sales growth and multiple division- and product-level production records.
Consumer Division: Strong Multi-Product Performance
Consumer NAP highlights: life NAP +10% (D2C life sales +20%, with >70% of D2C life leads from non-TV channels), total health NAP +22%, supplemental health +15%, long-term care +4%; Medicare Supplement NAP +49% for the year and +92% for the quarter; annuity collected premiums +9% year-over-year (Q4 +3%), in-force annuity values >$13B (+7%), brokerage/advisory client assets +24% to >$5B.
Worksite Division: Best Production Year Ever
Worksite reported record full-year insurance sales up 15% (Q4 insurance sales +13%); full-year life sales +36%, hospital indemnity +41%, accident +11%; geographic expansion contributed 11% of NAP growth and NAP from new group clients was +23%.
Improving Profitability and Operating Metrics
Operating return on equity (excluding significant items) improved to 11.4% (from a ~10% run rate in 2024); management cited one of the best operating performances on record; operating earnings per diluted share of $4.40 (Gary) and full-year operating EPS excluding significant items of $4.02 (Paul) exceeded guidance ranges.
Expense, Tax and Efficiency Beats
Full-year expense ratio (ex significant items) was 18.9%, better than the low end of original guidance; effective tax rate on operating income was 20.6%, below prior guidance of 22.0–22.5%.
Capital Return and Shareholder Metrics
Returned $386 million to shareholders (an 11% increase vs. 2024); deployed $320 million in share repurchases (+14% year-over-year) including $60 million in Q4, reducing weighted average diluted shares outstanding by ~8%.
Strong Investment and Yield Performance
New money rates exceeded 6% for 12 consecutive quarters (new money rate 6.11%); allocated net investment income up 6% for the year; record invested assets of $31 billion, 97% investment grade, average rating single-A; $1.6 billion of new investments in the quarter (avg rating A, avg duration 6 years).
Robust Capital and Liquidity Position
Consolidated risk-based capital ratio was 380% (target range 360%–390%); holding company liquidity ended year at $351 million (above $150 million minimum); debt-to-total-capital within target 25%–28%.
Clear 2026 Guidance and Multi-Year Investment Plan
2026 guidance: operating EPS $4.25–$4.45 (midpoint ~+8% vs 2025), expense ratio 18.8%–19.2%, effective tax rate ~22.5%, free cash flow $200–$250 million; three-year tech modernization plan of ~$170 million on track (2025 spend ~$20M, 2026 planned ~$75M).